Image
Melanie
Börries,
MD, PhD Professor
Project leader
Projects
Director of the Institute of Medical Informatics and Systems Medicine
Director of the Institute of Medical Informatics and Systems Medicine
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation—Immune signature correlates with responsePetya Apostolova, Stefanie Kreutmair, Cristina Toffalori, Marco Punta, Susanne Unger, Ann-Cathrin Burk, Claudia Wehr, Kristina Maas-Bauer, Wolfgang Melchinger, Eileen Haring, Rouven Hoefflin, Khalid Shoumariyeh, Valerie Hupfer, Eliza Maria Lauer, Sandra Duquesne, Theresa Lowinus, Nicolás Gonzalo Núñez, Chiara Alberti, Sara da Costa Pereira, Carla Helena Merten, Laura Power, Matthias Weiss, Caroline Böke, Dietmar Pfeifer, Reinhard Marks, Hartmut Bertz, Ralph Wäsch, Gabriele Ihorst, Bernhard Gentner, Justus Duyster, Melanie Boerries, Geoffroy Andrieux, Juergen Finke, Burkhard Becher, Luca Vago, Robert Zeiser 2023 British Journal of Haematology
|